Bill number does not exist. Enter a vaild keyword.
Facebook Twitter Youtube Channels

Committee Testimony and Witness Signup

HB0494 - Health Insurance - Primary Care Investment Targets - Reimbursement and Reporting

Health 2/12/2026 1:30:00 PM
Finance 3/24/2026 1:00:00 PM
As of: 7/14/2026 5:05:39 PM
Name Organization Position Testimony Committee
Delegate Bagnall, Delegate Bagnall FAV In Person - Oral Testimony
HLT
Jacobs, Douglas Maryland Health Care Commission FAV In Person - Oral Testimony
2026 Session - MHCC - HB 494 - Primary Care Invest
HLT
Sharp, David Maryland Health Care Commission FAV In Person - Oral Testimony
2026 Session - MHCC - HB 494 - Primary Care Invest
HLT
(MD), State of Maryland FAV 2026 Session - MHCC - HB 494 - Primary Care Invest HLT
Elliott, Robyn FAV In Person - Oral Testimony
2026 ACNM HB 494 House Side.pdf
2026 MCHS HB 494 House Side.pdf
HLT
Wise, Steve FAV HB0494_FAV_MDAFP_HI - Primcary Care Investment Tar HLT
Kauffman, Danna FAV In Person - Oral Testimony
HB0494_FAV_MedChi_HI - Primary Care Investment Tar
HLT
Price, Suzanne Concerned Citizen UNF No Testimony HLT
Krone, Christine FAV HB0494_FAV_MACHC_HI - Primary Care Investment Targ HLT
Delegate Bagnall, Delegate Bagnall FAV In Person - Oral Testimony
FIN
Jacobs, Douglas Maryland Health Care Commission FAV In Person - Oral Testimony
2026 Session - MHCC - HB 494 - Primary Care Invest
FIN
Kauffman, Danna FAV HB0494 - Senate_FAV_MedChi_HI - Primary Care Inves FIN
Krone, Christine FAV HB0494 - Senate_FAV_MACHC_HI - Primary Care Invest FIN
Elliott, Robyn FAV In Person - Oral Testimony
2026 ACNM HB 494 Senate Side.pdf
2026 MCHS HB 494 Senate Side.pdf
FIN
Blanchard, Tyler Aledade FAV In Person - Oral Testimony
Aledade - Tyler Blanchard - HB494 Testimony.pdf
FIN
Westrick, Sara AARP Maryland FAV HB 494 - Health Insurance - Primary Care Investmen FIN
Partners, Public Policy FAV No Testimony FIN
Kaplowitz, Richard KAP Year FAV HB0494 crossover FAV - Primary Care Investment Tar FIN
Bagnall, Delegate FAV HB494_HeatherBagnallTestimony FIN
Testimony, All N/A Merged Testimony as of 3-24-2026 at 947 AM FIN
Click to return on the top page